 | • レポートコード：QYR2104Z4540 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ペット用駆虫薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外部、内部、複合、注入）、用途別市場規模（犬、猫、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ペット用駆虫薬の市場動向 ・企業の競争状況、市場シェア ・ペット用駆虫薬の種類別市場規模（外部、内部、複合、注入） ・ペット用駆虫薬の用途別市場規模（犬、猫、その他） ・ペット用駆虫薬の北米市場規模2016-2027（アメリカ、カナダ） ・ペット用駆虫薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ペット用駆虫薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ペット用駆虫薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・ペット用駆虫薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Elanco、Boehringer Ingelheim、Ceva Sante Animale、Chanelle Group、Dechra、Durvet、First Priority、Jeffers、Manna Pro Products、Merck Animal Health、Ourofino、TTK Healthcare、Vetoquinol、Virbac、Zoetis） ・結論 |
Market Analysis and Insights: Global Pet Anthelmintic Drugs Market
The global Pet Anthelmintic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pet Anthelmintic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pet Anthelmintic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pet Anthelmintic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pet Anthelmintic Drugs market.
Global Pet Anthelmintic Drugs Scope and Market Size
Pet Anthelmintic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pet Anthelmintic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
External
Internal
Composite
Injection
Segment by Application
Dog
Cat
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Elanco
Boehringer Ingelheim
Ceva Sante Animale
Chanelle Group
Dechra
Durvet
First Priority
Jeffers
Manna Pro Products
Merck Animal Health
Ourofino
TTK Healthcare
Vetoquinol
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Anthelmintic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 External
1.2.3 Internal
1.2.4 Composite
1.2.5 Injection
1.3 Market by Application
1.3.1 Global Pet Anthelmintic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pet Anthelmintic Drugs Market Perspective (2016-2027)
2.2 Pet Anthelmintic Drugs Growth Trends by Regions
2.2.1 Pet Anthelmintic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pet Anthelmintic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Pet Anthelmintic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Pet Anthelmintic Drugs Industry Dynamic
2.3.1 Pet Anthelmintic Drugs Market Trends
2.3.2 Pet Anthelmintic Drugs Market Drivers
2.3.3 Pet Anthelmintic Drugs Market Challenges
2.3.4 Pet Anthelmintic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Anthelmintic Drugs Players by Revenue
3.1.1 Global Top Pet Anthelmintic Drugs Players by Revenue (2016-2021)
3.1.2 Global Pet Anthelmintic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Pet Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pet Anthelmintic Drugs Revenue
3.4 Global Pet Anthelmintic Drugs Market Concentration Ratio
3.4.1 Global Pet Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Anthelmintic Drugs Revenue in 2020
3.5 Pet Anthelmintic Drugs Key Players Head office and Area Served
3.6 Key Players Pet Anthelmintic Drugs Product Solution and Service
3.7 Date of Enter into Pet Anthelmintic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Anthelmintic Drugs Breakdown Data by Type
4.1 Global Pet Anthelmintic Drugs Historic Market Size by Type (2016-2021)
4.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2022-2027)
5 Pet Anthelmintic Drugs Breakdown Data by Application
5.1 Global Pet Anthelmintic Drugs Historic Market Size by Application (2016-2021)
5.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pet Anthelmintic Drugs Market Size (2016-2027)
6.2 North America Pet Anthelmintic Drugs Market Size by Type
6.2.1 North America Pet Anthelmintic Drugs Market Size by Type (2016-2021)
6.2.2 North America Pet Anthelmintic Drugs Market Size by Type (2022-2027)
6.2.3 North America Pet Anthelmintic Drugs Market Size by Type (2016-2027)
6.3 North America Pet Anthelmintic Drugs Market Size by Application
6.3.1 North America Pet Anthelmintic Drugs Market Size by Application (2016-2021)
6.3.2 North America Pet Anthelmintic Drugs Market Size by Application (2022-2027)
6.3.3 North America Pet Anthelmintic Drugs Market Size by Application (2016-2027)
6.4 North America Pet Anthelmintic Drugs Market Size by Country
6.4.1 North America Pet Anthelmintic Drugs Market Size by Country (2016-2021)
6.4.2 North America Pet Anthelmintic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pet Anthelmintic Drugs Market Size (2016-2027)
7.2 Europe Pet Anthelmintic Drugs Market Size by Type
7.2.1 Europe Pet Anthelmintic Drugs Market Size by Type (2016-2021)
7.2.2 Europe Pet Anthelmintic Drugs Market Size by Type (2022-2027)
7.2.3 Europe Pet Anthelmintic Drugs Market Size by Type (2016-2027)
7.3 Europe Pet Anthelmintic Drugs Market Size by Application
7.3.1 Europe Pet Anthelmintic Drugs Market Size by Application (2016-2021)
7.3.2 Europe Pet Anthelmintic Drugs Market Size by Application (2022-2027)
7.3.3 Europe Pet Anthelmintic Drugs Market Size by Application (2016-2027)
7.4 Europe Pet Anthelmintic Drugs Market Size by Country
7.4.1 Europe Pet Anthelmintic Drugs Market Size by Country (2016-2021)
7.4.2 Europe Pet Anthelmintic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pet Anthelmintic Drugs Market Size (2016-2027)
8.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type
8.2.1 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application
8.3.1 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region
8.4.1 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pet Anthelmintic Drugs Market Size (2016-2027)
9.2 Latin America Pet Anthelmintic Drugs Market Size by Type
9.2.1 Latin America Pet Anthelmintic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Pet Anthelmintic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Pet Anthelmintic Drugs Market Size by Type (2016-2027)
9.3 Latin America Pet Anthelmintic Drugs Market Size by Application
9.3.1 Latin America Pet Anthelmintic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Pet Anthelmintic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Pet Anthelmintic Drugs Market Size by Application (2016-2027)
9.4 Latin America Pet Anthelmintic Drugs Market Size by Country
9.4.1 Latin America Pet Anthelmintic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Pet Anthelmintic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Anthelmintic Drugs Market Size (2016-2027)
10.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type
10.2.1 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application
10.3.1 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country
10.4.1 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Elanco
11.1.1 Elanco Company Details
11.1.2 Elanco Business Overview
11.1.3 Elanco Pet Anthelmintic Drugs Introduction
11.1.4 Elanco Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.1.5 Elanco Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pet Anthelmintic Drugs Introduction
11.2.4 Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Ceva Sante Animale
11.3.1 Ceva Sante Animale Company Details
11.3.2 Ceva Sante Animale Business Overview
11.3.3 Ceva Sante Animale Pet Anthelmintic Drugs Introduction
11.3.4 Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.3.5 Ceva Sante Animale Recent Development
11.4 Chanelle Group
11.4.1 Chanelle Group Company Details
11.4.2 Chanelle Group Business Overview
11.4.3 Chanelle Group Pet Anthelmintic Drugs Introduction
11.4.4 Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.4.5 Chanelle Group Recent Development
11.5 Dechra
11.5.1 Dechra Company Details
11.5.2 Dechra Business Overview
11.5.3 Dechra Pet Anthelmintic Drugs Introduction
11.5.4 Dechra Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.5.5 Dechra Recent Development
11.6 Durvet
11.6.1 Durvet Company Details
11.6.2 Durvet Business Overview
11.6.3 Durvet Pet Anthelmintic Drugs Introduction
11.6.4 Durvet Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.6.5 Durvet Recent Development
11.7 First Priority
11.7.1 First Priority Company Details
11.7.2 First Priority Business Overview
11.7.3 First Priority Pet Anthelmintic Drugs Introduction
11.7.4 First Priority Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.7.5 First Priority Recent Development
11.8 Jeffers
11.8.1 Jeffers Company Details
11.8.2 Jeffers Business Overview
11.8.3 Jeffers Pet Anthelmintic Drugs Introduction
11.8.4 Jeffers Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.8.5 Jeffers Recent Development
11.9 Manna Pro Products
11.9.1 Manna Pro Products Company Details
11.9.2 Manna Pro Products Business Overview
11.9.3 Manna Pro Products Pet Anthelmintic Drugs Introduction
11.9.4 Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.9.5 Manna Pro Products Recent Development
11.10 Merck Animal Health
11.10.1 Merck Animal Health Company Details
11.10.2 Merck Animal Health Business Overview
11.10.3 Merck Animal Health Pet Anthelmintic Drugs Introduction
11.10.4 Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.10.5 Merck Animal Health Recent Development
11.11 Ourofino
11.11.1 Ourofino Company Details
11.11.2 Ourofino Business Overview
11.11.3 Ourofino Pet Anthelmintic Drugs Introduction
11.11.4 Ourofino Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.11.5 Ourofino Recent Development
11.12 TTK Healthcare
11.12.1 TTK Healthcare Company Details
11.12.2 TTK Healthcare Business Overview
11.12.3 TTK Healthcare Pet Anthelmintic Drugs Introduction
11.12.4 TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.12.5 TTK Healthcare Recent Development
11.13 Vetoquinol
11.13.1 Vetoquinol Company Details
11.13.2 Vetoquinol Business Overview
11.13.3 Vetoquinol Pet Anthelmintic Drugs Introduction
11.13.4 Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.13.5 Vetoquinol Recent Development
11.14 Virbac
11.14.1 Virbac Company Details
11.14.2 Virbac Business Overview
11.14.3 Virbac Pet Anthelmintic Drugs Introduction
11.14.4 Virbac Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.14.5 Virbac Recent Development
11.15 Zoetis
11.15.1 Zoetis Company Details
11.15.2 Zoetis Business Overview
11.15.3 Zoetis Pet Anthelmintic Drugs Introduction
11.15.4 Zoetis Revenue in Pet Anthelmintic Drugs Business (2016-2021)
11.15.5 Zoetis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pet Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of External
Table 3. Key Players of Internal
Table 4. Key Players of Composite
Table 5. Key Players of Injection
Table 6. Global Pet Anthelmintic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pet Anthelmintic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pet Anthelmintic Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Pet Anthelmintic Drugs Market Share by Regions (2016-2021)
Table 10. Global Pet Anthelmintic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Pet Anthelmintic Drugs Market Share by Regions (2022-2027)
Table 12. Pet Anthelmintic Drugs Market Trends
Table 13. Pet Anthelmintic Drugs Market Drivers
Table 14. Pet Anthelmintic Drugs Market Challenges
Table 15. Pet Anthelmintic Drugs Market Restraints
Table 16. Global Pet Anthelmintic Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Pet Anthelmintic Drugs Market Share by Players (2016-2021)
Table 18. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Anthelmintic Drugs as of 2020)
Table 19. Ranking of Global Top Pet Anthelmintic Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Pet Anthelmintic Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pet Anthelmintic Drugs Product Solution and Service
Table 23. Date of Enter into Pet Anthelmintic Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pet Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Pet Anthelmintic Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Pet Anthelmintic Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Pet Anthelmintic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Pet Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Pet Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Pet Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Pet Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Pet Anthelmintic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Pet Anthelmintic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Pet Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Pet Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Pet Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Pet Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Pet Anthelmintic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Pet Anthelmintic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Pet Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Pet Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Pet Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Pet Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Pet Anthelmintic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Pet Anthelmintic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Elanco Company Details
Table 64. Elanco Business Overview
Table 65. Elanco Pet Anthelmintic Drugs Product
Table 66. Elanco Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 67. Elanco Recent Development
Table 68. Boehringer Ingelheim Company Details
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Pet Anthelmintic Drugs Product
Table 71. Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Development
Table 73. Ceva Sante Animale Company Details
Table 74. Ceva Sante Animale Business Overview
Table 75. Ceva Sante Animale Pet Anthelmintic Drugs Product
Table 76. Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 77. Ceva Sante Animale Recent Development
Table 78. Chanelle Group Company Details
Table 79. Chanelle Group Business Overview
Table 80. Chanelle Group Pet Anthelmintic Drugs Product
Table 81. Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 82. Chanelle Group Recent Development
Table 83. Dechra Company Details
Table 84. Dechra Business Overview
Table 85. Dechra Pet Anthelmintic Drugs Product
Table 86. Dechra Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 87. Dechra Recent Development
Table 88. Durvet Company Details
Table 89. Durvet Business Overview
Table 90. Durvet Pet Anthelmintic Drugs Product
Table 91. Durvet Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 92. Durvet Recent Development
Table 93. First Priority Company Details
Table 94. First Priority Business Overview
Table 95. First Priority Pet Anthelmintic Drugs Product
Table 96. First Priority Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 97. First Priority Recent Development
Table 98. Jeffers Company Details
Table 99. Jeffers Business Overview
Table 100. Jeffers Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 101. Jeffers Recent Development
Table 102. Manna Pro Products Company Details
Table 103. Manna Pro Products Business Overview
Table 104. Manna Pro Products Pet Anthelmintic Drugs Product
Table 105. Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 106. Manna Pro Products Recent Development
Table 107. Merck Animal Health Company Details
Table 108. Merck Animal Health Business Overview
Table 109. Merck Animal Health Pet Anthelmintic Drugs Product
Table 110. Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 111. Merck Animal Health Recent Development
Table 112. Ourofino Company Details
Table 113. Ourofino Business Overview
Table 114. Ourofino Pet Anthelmintic Drugs Product
Table 115. Ourofino Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 116. Ourofino Recent Development
Table 117. TTK Healthcare Company Details
Table 118. TTK Healthcare Business Overview
Table 119. TTK Healthcare Pet Anthelmintic Drugs Product
Table 120. TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 121. TTK Healthcare Recent Development
Table 122. Vetoquinol Company Details
Table 123. Vetoquinol Business Overview
Table 124. Vetoquinol Pet Anthelmintic Drugs Product
Table 125. Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 126. Vetoquinol Recent Development
Table 127. Virbac Company Details
Table 128. Virbac Business Overview
Table 129. Virbac Pet Anthelmintic Drugs Product
Table 130. Virbac Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 131. Virbac Recent Development
Table 132. Zoetis Company Details
Table 133. Zoetis Business Overview
Table 134. Zoetis Pet Anthelmintic Drugs Product
Table 135. Zoetis Revenue in Pet Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 136. Zoetis Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pet Anthelmintic Drugs Market Share by Type: 2020 VS 2027
Figure 2. External Features
Figure 3. Internal Features
Figure 4. Composite Features
Figure 5. Injection Features
Figure 6. Global Pet Anthelmintic Drugs Market Share by Application: 2020 VS 2027
Figure 7. Dog Case Studies
Figure 8. Cat Case Studies
Figure 9. Others Case Studies
Figure 10. Pet Anthelmintic Drugs Report Years Considered
Figure 11. Global Pet Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Pet Anthelmintic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pet Anthelmintic Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Pet Anthelmintic Drugs Market Share by Regions (2022-2027)
Figure 15. Global Pet Anthelmintic Drugs Market Share by Players in 2020
Figure 16. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Anthelmintic Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Pet Anthelmintic Drugs Revenue in 2020
Figure 18. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Pet Anthelmintic Drugs Market Share by Type (2016-2027)
Figure 22. North America Pet Anthelmintic Drugs Market Share by Application (2016-2027)
Figure 23. North America Pet Anthelmintic Drugs Market Share by Country (2016-2027)
Figure 24. United States Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pet Anthelmintic Drugs Market Share by Type (2016-2027)
Figure 28. Europe Pet Anthelmintic Drugs Market Share by Application (2016-2027)
Figure 29. Europe Pet Anthelmintic Drugs Market Share by Country (2016-2027)
Figure 30. Germany Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pet Anthelmintic Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Pet Anthelmintic Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Pet Anthelmintic Drugs Market Share by Region (2016-2027)
Figure 40. China Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pet Anthelmintic Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Pet Anthelmintic Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Pet Anthelmintic Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pet Anthelmintic Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Pet Anthelmintic Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Pet Anthelmintic Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Pet Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Elanco Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 60. Boehringer Ingelheim Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 61. Ceva Sante Animale Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 62. Chanelle Group Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 63. Dechra Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 64. Durvet Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 65. First Priority Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 66. Jeffers Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 67. Manna Pro Products Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 68. Merck Animal Health Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 69. Ourofino Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 70. TTK Healthcare Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 71. Vetoquinol Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 72. Virbac Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 73. Zoetis Revenue Growth Rate in Pet Anthelmintic Drugs Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界のイロプロスト薬市場規模・現状・予測（2021年-2027年） Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. North America is estimated to have a major share in the global market with 75%. Market Analysis…- 世界の不妊症治療薬市場規模・現状・予測（2021年-2027年） Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins. Market compet…
- 世界のチロシンヒドロキシラーゼ欠損症治療薬市場規模・現状・予測（2021年-2027年） The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…
- 世界のチロシンヒドロキシラーゼ欠損症治療薬市場規模・現状・予測（2021年-2027年） The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…
- 世界の糖尿病網膜症治療薬市場規模・現状・予測（2021年-2027年） Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes. The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising…